SPECIAL NOTICE
65 -- Coagulation Cost per Reportable Result (CPRR), Equipment and Reagents
- Notice Date
- 9/10/2025 8:41:30 AM
- Notice Type
- Special Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- DEFENSE HEALTH AGENCY SAN ANTONIO TX 78230 USA
- ZIP Code
- 78230
- Solicitation Number
- HT940825QE0010
- Response Due
- 9/12/2025 8:00:00 AM
- Archive Date
- 09/27/2025
- Point of Contact
- David Erpelding, Carolynn Benn, Phone: 2108684971
- E-Mail Address
-
david.k.erpelding.civ@health.mil, carolynn.j.benn.civ@health.mil
(david.k.erpelding.civ@health.mil, carolynn.j.benn.civ@health.mil)
- Description
- The Healthcare Contracting Division � South (HCD-S), San Antonio, Texas, intends to award a firm-fixed-price (FFP) sole source contract to Diagnostica Stago of Parsippany, New Jersey to conduct Coagulation testing for Keesler Medical Center, Keesler Air Force Base, Mississippi. As a Cost-per-Reportable-Result (CPRR) vehicle, the contractor also provides all equipment, consumables, and services necessary to perform the required testing. The contract will be awarded under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b). The applicable NAICS code for this requirement is 325413, In-Vitro Diagnostics Substance Manufacturing. The Small Business Size Standard is 1,250 employees. Diagnostica Stago is an ""other-than-small business."" The contract will be awarded on or before 1 October 2025. NOTE: This contract will be issued for a performance period of 1 October 2025 -31 March 2026, with two (2) two-month option period. This notice is not a request for competitive quotes. All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date to determine if any other entity is capable of performing the required testing. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. In order for the Government to consider another source, the capability statement must demonstrate the source's ability to 1) provide the required testing; 2) deliver, install, and validate the analyzer(s) to ensure patient-ready testing by 01 October 2025; and 3) ability to connect to the Defense Health Agency/Military Health System network. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored as a result of this notice and any information provided will not be used as part of any subsequent solicitation requirement. No telephonic inquires will be honored. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. NOTE: INTERESTED VENDORS MUST RESPOND TO THIS NOTICE TO THE BELOW POCs ON OR BEFORE 12 SEPTEMBER 2025 BY 10 AM CENTRAL TIME IN ORDER TO BE CONSIDERED.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/7887923fde86413a81348001044cb367/view)
- Place of Performance
- Address: Biloxi, MS 39534, USA
- Zip Code: 39534
- Country: USA
- Zip Code: 39534
- Record
- SN07585114-F 20250912/250910230045 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |